TABLE 2.
The relationship between anticholinergic burden scales and polypharmacy
| Scale | Odds ratios | 95% CI | p |
|---|---|---|---|
| ACB | 2.32 | 1.764–3.046 | <0.001 |
| ARS | 3.11 | 1.919–5.032 | <0.001 |
| Chew | 1.90 | 1.541–2.345 | <0.001 |
| ADS | 2.35 | 1.785–3.082 | <0.001 |
| AAS | 1.44 | 1.109–1.871 | 0.006 |
| ALS | 3.17 | 2.163–4.646 | <0.001 |
| CrAS | 3.3 | 2.229–4.871 | <0.001 |
| Duran | 3.46 | 2.173–5.519 | <0.001 |
| ABC | 2.14 | 1.417–3.238 | <0.001 |
| DBI | 10.87 | 5.446–21.680 | <0.001 |
All adjusted for age. AAS: Anticholinergic activity scale; ABC: Anticholinergic burden classification; ACB: Anticholinergic cognitive burden scale; ADS: Anticholinergic drug scale; ALS: Anticholinergic load scale; ARS: Anticholinergic risk scale; CI: Confidence interval; CrAS: Clinician-rated anticholinergic scale; DBI: Drug burden index.